Quanterix Corp
Quanterix Corp (QTRX) Options Open Interest
QTRX options open interest is 2,605 contracts. The 2-week average daily volume is 104 contracts across the chain.
Read more
Monitoring QTRX open interest helps you see where real money is positioned on Quanterix Corp's options and which strikes are attracting the most commitment from traders. Quanterix Corp's open interest reflects the total number of outstanding contracts that have not been closed or exercised, making it a powerful gauge of liquidity, conviction, and potential support and resistance zones. Use our scanner to monitor QTRX options open interest in real time and find the strikes that matter.
Open interest is distinct from volume: volume counts how many contracts are traded in a session, while open interest counts how many remain open at the end of the day. Rising QTRX options open interest alongside rising volume suggests new positions are being built, while falling open interest signals positions are being closed. Heavy open interest at specific strikes often acts as a magnet near expiration and can hint at where dealers and large traders expect Quanterix Corp to settle.
Quanterix Corporation, a life sciences company, engages in development and marketing of digital immunoassay platforms that advances precision health for life sciences research and diagnostics in North America, Europe, the Middle East, Africa, and the Asia Pacific regions. It offers HD-X instrument, a sensitive automated multiplex protein detection platform; and SR-X instrument that enables researchers to apply Simoa detection technology in various applications, including direct detection of nucleic acids. The company also provides SP-X instrument that is based on Simoa planar array technology for the measurement of multiplex chemiluminescent immunoassays.
The company's products include assay kits and other consumables such as reagents. In addition, it offers contract research services, including sample testing, homebrew assay development, and custom development services. The company primarily operates in the areas of neurology, oncology, cardiology, infectious diseases, and inflammation. It sells its products for the life science research sector primarily to laboratories associated with academic and governmental research institutions, as well as pharmaceutical, biotechnology, and contract research companies through a direct sales force, support organizations, and distributors or sales agents. The company was formerly known as Digital Genomics, Inc. and changed its name to Quanterix Corporation in August 2007. Quanterix Corporation was incorporated in 2007 and is headquartered in Billerica, Massachusetts.
Pin risk into expiration, dealer positioning, liquidity checks for large orders — all of it starts with knowing where QTRX open interest is concentrated. Our scanner maps Quanterix Corp's open interest across every strike and expiry, flags unusual buildups, and lets you drill into the contracts that institutional money is actually holding. Trade Quanterix Corp's options open interest as the signal it is, not as an afterthought.
| 2.50 | — | 0.95 | 0.95 | 200% | +0.7655 | 296 |
| 5.00 | — | 0.05 | 0.05 | 133% | +0.1125 | 6 |
| 7.50 | — | 0.95 | 0.95 | 551% | +0.5241 | 0 |
| 2.50 | — | 1.00 | 1.00 | 497% | -0.2089 | 0 |
| 5.00 | 1.25 | 2.60 | 1.93 | 160% | -0.8285 | 0 |
| 7.50 | 3.70 | 5.10 | 4.40 | 230% | -0.8883 | 0 |
As of September 23, 2026
Follow the money
Track QTRX open interest across every strike and expiration, identify where conviction is building, and trade with the positioning data on your side.
Start your 14-day free trial→